Antibody response against SARS-CoV-2 Delta and Omicron variants after third-dose BNT162b2 vaccination in allo-HCT recipients., Canti, Lorenzo, and Ehx Grégory , Cancer Cell, 2022 Apr 11, Volume 40, Issue 4, (2022)